Portfolio

We are enabling companies to turn their boldest ambitions into world-changing breakthroughs in healthcare and technology.

Portfolio

Spotlights Portfolio List

Initial Investment
Created 2018

Pioneering CRISPR base editing for precision genetic medicines to treat disease.

Beam Therapeutics

Beam Therapeutics

Beam Therapeutics

Initial Investment
2016

The leading POS and SaaS platform for restaurants.

Toast

Toast

Toast

Initial Investment
2019

Providing evidence-based virtual eating disorder treatment.

Equip

Equip

Equip

Initial Investment
2014

Acquired by Vertex

Developing cell therapies for treating type 1 diabetes.

Semma Therapeutics

Semma Therapeutics

Semma Therapeutics

Initial Investment
2017

Tech-enabled health insurance and clinical services for improving senior healthcare.

Devoted Health

Devoted Health

Devoted Health

Initial Investment
2013

Specializing in global payment solutions for complex, high-value transactions for various industries.

Flywire

Flywire

Flywire

Initial Investment
2011

Developing and commercializing high-quality biologic medicines.

Innovent Biologics

Innovent Biologics

Innovent Biologics

Initial Investment
2017

Leading commercial platform for the travel & hospitality industry.

Lighthouse

Lighthouse

Lighthouse

Initial Investment
2015

Acquired by Appriss Health

Enables real-time patient information sharing among providers through healthcare coordination.

PatientPing

PatientPing

PatientPing

Initial Investment
2018

Modern software and AI tools for bioscientists.

Benchling

Benchling

Benchling

Initial Investment
Created 2015

Developing therapies for neurodegenerative diseases through rigorous research.

Denali Therapeutics

Denali Therapeutics

Denali Therapeutics

Initial Investment
2011

Acquired by One Medical

Focused on value-based care for Medicare beneficiaries.

Iora Health

Iora Health

Iora Health

Portfolio List

Acquired by Sokin

Offers digital banking services for children and families.

Acquired by Sokin

The companies identified do not represent all the companies purchased, sold, or recommended for portfolios advised by F-Prime.

close

close